Page 9 - Human Data Science News Today

IQVIA report forecasts global medicine spending to hit $1.6 trillion in 2025 30th April 2021 A new report looking at global medicine spending and usage trends has forecasted growth for the global medicine market through 2025, noting a ‘modest’ impact on pre-pandemic drivers of medicine use and spending from COVID-19. The report, released by the IQVIA Institute for Human Data Science, has projected global spending on medicines to grow at 3-6% CAGR through 2025, reaching approximately $1.6 tr...

Ninian Reid / Flickr cc While Europe reports its first significant decline in COVID-19 cases in 2 months, infections in India continue to rage as the worlds case total approaches 150 million. More resources to India Indias COVID-19 surge continues unabated, with 386,829 new cases and 3,501 deaths, according to World O Meter. The daily case number is the highest any country has ever recorded, and it marks the ninth day in a row the country has reported more than 300,000. The crisis has galvanize...

FDA has not approved any biosimilars in 2021 after only approving three in 2020. EMA approves second Novolog® (insulin aspartate), fifth Avastin® (bevacizumab), eighth Neulasta® (pegfilgrastim), and twelfth Humira® (adalimumab) biosimilars, and withdraws approval of an adalimumab biosimilar and a pegfilgrastim biosimilar. Given the increasing number of approved biosimilars in Europe, biosimilar manufacturers are increasingly deciding to not market their products due to commercial reasons. A...

PHOENIX – Cancer screenings in the U.S. have plunged since the start of the pandemic almost a year ago, prompting health advocates to increase calls for the public to stop postponing these potentially life-saving procedures. More than one-third of adults have failed to receive recommended cancer screenings during the pandemic, according to “Cancer Won’t Wait and Neither Should You,” a bulletin published by the American Cancer Society and the National Comprehensive Canc...

Feb. 22, 2021 Experts say more than a third of adults have not received recommended cancer screenings during the pandemic – in part due to fear of contracting COVID-19. That worries advocates, who now are urging Americans to get these potentially life-saving procedures. (Photo by Specialist 2nd Class Joseph Moon/U.S. Navy) PHOENIX – Cancer screenings in the U.S. have plunged since the start of the pandemic almost a year ago, prompting health advocates to increase calls for the public to st...

Report: More than 80,000 cancer diagnoses could be missed or delayed because of pandemic-related disruptions.

Posted on 600 Total national prescription opioid use has declined by 60% from the peak volume in 2011 after another year of double-digit decline that is expected in 2020, according to the latest report from the IQVIA™ Institute for Human Data Science, Prescription Opioid Trends in the United States: Measuring and Understanding Progress in the Opioid Crisis. Decreases in prescription opioid volume over the past nine years have been...

Dec 17, 2020 13:00 UTC Prescription Opioid Use in the U.S. has Declined by 60% from 2011 Peak, According to New Report from the IQVIA™ Institute for Human Data Science DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(Business Wire)--Total national prescription opioid use has declined by 60% from the peak volume in 2011 after another year of double-digit decline that is expected in 2020, according to the latest report from the IQVIA™ Institute for Human Data Science, Prescription Opioid Tr...